2220 Kernan Drive
Baltimore, MD 21207
1-888-4KERNAN (453-7626)

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Ask Our Experts

Get answers to your specific medical questions from Kernan Hospital experts.

Note: This is for informational purposes only. Doctors cannot provide a diagnosis via e-mail.

 

Related Content

Kernan Hospital

Our Services

Patient Success Stories

Our Doctors

Lambert-Eaton syndrome - Treatment

Alternative Names

Myasthenic syndrome; Eaton-Lambert syndrome; Lambert-Eaton myasthenic syndrome; LEMS

Treatment:

The main goals of treatment are to:

  • Identify and treat any underlying disorders, such as lung cancer
  • Give treatment to help with the weakness

A treatment called plasma exchange usually improves symptoms. Plasma exchange involves removing blood plasma from the body and replacing it with donated plasma. This helps to make sure that any harmful proteins (antibodies) that are interfering with nerve function are removed from the body.

Plasmapheresis may also be effective. During this treatment, the blood is removed from the body. The plasma is separated, the antibodies are removed, and the plasma is returned to the body.

Medications that suppress the immune response, such as prednisone, may improve symptoms in some cases. Medications may also include:

  • Anticholinesterase medications such as neostigmine or pyridostigmine (although these are not very effective when given alone)
  • 3, 4-diaminopyridine, which increases the release of acetylcholine from nerve cells

Expectations (prognosis):

The symptoms of Lambert-Eaton syndrome may improve by treating the underlying disease, suppressing the immune system, or removing the antibodies. However, not everyone responds well to treatment.

Complications:

  • Difficulty breathing, including respiratory failure
  • Difficulty swallowing
  • Infections, such as pneumonia
  • Injuries from falls and problems with coordination

Calling your health care provider:

Call your health care provider if symptoms of this condition develop.

  • Reviewed last on: 8/27/2010
  • David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Daniel B. Hoch, PhD, MD, Assistant Professor of Neurology, Harvard Medical School, Department of Neurology, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

References

Vincent A, Newsom-Davis J. Disorders of neuromuscular transmission. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 448.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com